Huge Congratulations to Markus Sauer on his incredible achievement at the Jungfrau Marathon 💪🎉🏆! Last Saturday, Markus completed 42.2 kilometres and 1800 metres of altitude in brilliant sunshine in an amazing time of 4 hours and 50 minutes 🌄. Markus proves that you can achieve your goals and celebrate great successes with type 1 diabetes. We are proud that mylife Loop was able to support him in managing his diabetes during the marathon. We're excited to catch up with him soon to hear about his experience, how he managed his diabetes during the race, and how he's recovering from this incredible feat. But for now, Markus definitely deserves a well-earned break. Rest up, Markus - you have earned it 🚀💚. #mylifeloop #ypsomed #diabetesmanagement #diabetessport
Ypsomed AG
Herstellung medizinischer Geräte
Making selfcare simpler and easier.
Info
Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company will celebrate its 40th anniversary in 2024. As a leader in innovation and technology, it is a preferred partner of pharmaceutical and biotech companies for pens, autoinjectors and pump systems for administering liquid medications. Ypsomed presents and markets its product portfolios under the umbrella brand mylife Diabetescare directly to patients, pharmacies and hospitals as well as under Ypsomed Delivery Systems in business-to-business operations with pharmaceutical companies. Ypsomed is headquartered in Burgdorf, Switzerland. The company has a global network of production facilities, subsidiaries and distribution partners. Ypsomed has over 2,200 employees worldwide.
- Website
-
https://www.ypsomed.com/en/company/ypsostories.html
Externer Link zu Ypsomed AG
- Branche
- Herstellung medizinischer Geräte
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Burgdorf
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2003
- Spezialgebiete
- diabetes care, manufacturer, injection systems, selfcare solutions, blood glucose monitoring systems, infusion systems, insulin pumps und digital health
Orte
-
Primär
Brunnmattstrasse 6
Burgdorf, 3401, CH
-
Weissensteinstrasse 26
Solothurn, 4503, CH
Beschäftigte von Ypsomed AG
-
Simon Michel
CEO and Member of the Board at Ypsomed Group and Member of the Swiss National Council
-
Kristen Garland, MAN, RD, CDE
-
Carlos Reboll Romero
General Manager | Sustainable Growth and Expansion | New Market Access | Product Commercialisation | Investment in People | Experience in Multiple…
-
Frederic Richard
Ypsomed Diabetes Care Business Development Director
Updates
-
Day two at EASD is in full swing 💚. If you are attending, stop by and say hello 🖐️ – we are here to discuss how our mylife Loop solution can make a difference for people with diabetes. 📣 Do not miss our Hot Topic Session 🔥 this Friday with Prof. Helen Murphy and Dr. Pilar Beato-Vibora. European Association for the Study of Diabetes e.V. (EASD) #EASD2024 #mylifeloop #DiabetesManagement #ypsomed
-
-
Arigatou gozaimasu Tokyo 💙 We had an inspiring two days at the PDA Tokyo Conference. A big thank you to everyone who stopped by our booth. The future of healthcare innovation looks bright, and we were thrilled to be a part of it 🤩. PDA - Parenteral Drug Association #pdajapan #SelfcareSolutions #ypsomed #DrugDelivery
-
-
Unlock six business opportunities for pharma companies investing in digital health solutions 🔓🚀. Gain insights from industry experts and explore three key enablers for successful digital health solutions, including how to build effective partnerships between pharma and digital health companies. S3 Connected Health, Roche, ViiV Healthcare #DigitalHealth #ypsomed #DigitalPartnership #SelfcareSolutions #pharma
-
Hola from Madrid 💚 We are excited to kick off the first day of the conference and showcase our mylife Loop – the automated insulin delivery system that runs right from your smartphone. Visit our booth to learn more and see it in action 🙌 Looking forward to connecting with you all 👋🚀. European Association for the Study of Diabetes e.V. (EASD) #EASD2024 #mylifeloop #DiabetesManagement #ypsomed
-
-
Accompanying your individual practical work (IPA) with a high-quality video 🎥 and then completing it with a very good grade? Lukas, apprentice polymechanic, did just that and successfully passed his IPA on die-sinking EDM 👏. #ypsomed #apprenticship #polymechanic
Successful polymechanic at Ypsomed.
ypsomed.com
-
#SelfcareTherapies 💙 Cancer, encompassing a range of complex and multifaceted conditions, presents significant physical and emotional challenges for individuals and families. Managing and treating cancer effectively requires advanced therapies, including chemotherapy, targeted therapy, and immunotherapy. We are proud to contribute to the fight against cancer by making these therapies more accessible. Our solutions and partnerships with pharmaceutical companies worldwide make selfcare for patients simpler and easier. #ypsomed #healthcare #selfcare #oncology
-
-
40 years of Ypsomed AG 🎉💙🎈! We celebrated our company anniversary at the end of August at the Attisholz site - with over 3500 colleagues, their families and DJ Bobo 🤩. #40yearsypsomed #ypsomed #djbobo
Lots of sun, fun and DJ BoBo
ypsomed.com
-
Do not miss our Hot Topic Session 🔥 at EASD next week 💚! 📣 Prof. Helen Murphy, Professor of Medicine (Diabetes and Antenatal Care) of East Anglia, will open our session at about “mylife CamAPS FX : a unique solution while planning and throughout pregnancy ”. 📣 Dr. Pilar Beato-Vibora, diabetes consultant at the Endocrinology & Nutrition Department in Badajoz University Hospital, provides application in the clinical practice: “insights from a center initiating the journey with mylife CamAPS FX” European Association for the Study of Diabetes e.V. (EASD) #easd2024 #camapsfx #mylifeloop #ypsomed
-
-
What is your key driver for digital health solutions? Vote in our poll and share your perspective 🙋♀️ 👍! #DigitalHealth #ypsomed
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.